P. v. Jennings CA4/2

CourtListener 902604CalctappJun 14, 2013

Full text

Filed 6/14/13 P. v. Jennings CA4/2

NOT TO BE PUBLISHED IN OFFICIAL REPORTS
California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for
publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication
or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FOURTH APPELLATE DISTRICT

DIVISION TWO

THE PEOPLE,

Plaintiff and Respondent, E055053

v. (Super.Ct.Nos. RIF151367 and
RIF10003947)
DESTINY CAROLINE JENNINGS,
OPINION
Defendant and Appellant.

APPEAL from the Superior Court of Riverside County. Harry A. Staley, Judge.

(Retired judge of the Kern Super. Ct. assigned by the Chief Justice pursuant to art. VI,

§ 6 of the Cal. Const.) Affirmed with directions.

Gail Ganaja, under appointment by the Court of Appeal, for Defendant and

Appellant.

Kamala D. Harris, Attorney General, Dane R. Gillette, Chief Assistant Attorney

General, Julie L. Garland, Assistant Attorney General, Melissa Mandel and Marissa

Bejarano, Deputy Attorneys General, for Plaintiff and Respondent.

1
Defendant and appellant Destiny Caroline Jennings was convicted by a jury of

multiple drug-related charges, but this appeal challenges only her conviction of

possession of a controlled substance, to wit, Xanax (alprazolam). (Health & Saf. Code, §

11375 1 [see infra].) She argues that the evidence was insufficient to support her

conviction because the criminalist who testified at trial did not conduct a chemical

analysis of the seized pills and did not testify with certainty that the pills were Xanax.

We disagree and affirm the judgment with directions.

STATEMENT OF FACTS

Due to the limited nature of appellant’s challenge, no detailed recitation of the

facts is necessary. Police entered appellant’s residence in Riverside to serve a search

warrant. Among the items found were 14 pills, which the officer serving the warrant

believed to be a controlled substance, and one and one-half “bars,” which he also

believed to be the same controlled substance. Other substances were also seized that will

be discussed below.

Testimony concerning the pills (the bar was not tested) was given by a criminalist

employed by the Department of Justice. The witness testified that if a submitted

substance appeared to be a pharmaceutical pill, the usual analysis would include only

visual identification in connection with reference materials. For the pills in question, the

criminalist compared the pills to samples shown in the “Drug ID Bible” and found a

match for the pills’ “markings” as tablets containing a preparation of alprazolam, or

1All further statutory references are to the Health and Safety Code unless
otherwise indicated.

2
Xanax. On cross-examination, she agreed that she did not have a “conclusive answer”

for what the pills contained but that the pills in question were “similar” to those seen on

the CD-ROM used. She also explained that the “visual identification [] could indicate to

us what the tablet could contain.”

DISCUSSION

Appellant argues that the criminalist backtracked on her initial more positive

identification of the pills and that her subsequent testimony did, with respect to the

inconclusive nature of her opinion, mean that there was not legally substantial evidence to

support the conviction for possession of alpralozam. That is, that the criminalist’s

testimony was not reasonable, credible, and of solid value, such that a reasonable trier of

fact could find the defendant guilty beyond a reasonable doubt. (Jackson v. Virginia

(1979) 443 U.S. 307, 313-324; People v. Snow (2003) 30 Cal.4th 43, 66.) We review the

evidence in the light most favorable to the judgment. (People v. Jones (1990) 51 Cal.3d

294, 314.)

We may agree, arguendo, that the criminalist’s testimony could have usefully been

amplified; for example, if she had been asked to describe the identifying markings and

size and shape of the pills, and asked expressly whether the sample in the reference was

similarly sized, shaped, and marked. However, the criminalist certainly could base her

opinion of the pills’ composition on an established reference text or treatise (see Evid.

Code, § 801, subd. (b)), and indeed there is no contention that the pills did not match the

3
reference’s depiction of alprazolam; certainly there was no evidence to rebut the

criminalist’s testimony that they did. 2

What appellant argues is that there was insufficient evidence that the pills actually

contained alprazolam, even if they matched legitimately manufactured pharmaceutical

products containing that substance, because they were not chemically analyzed.

Chemical analysis of a substance is not always necessary to establish its nature or

content, which may be shown circumstantially. (See People v. Sonleitner (1986) 183

Cal.App.3d 364, 369, and cases cited.) Of course, the criminalist could not testify

positively that the pills contained alprazolam without a chemical analysis, and her

testimony does no more than reflect this obvious point. But this does not mean that the

pills’ appearance does not constitute substantial evidence that they contained alprazolam.

Appellant suggests that the “visual resemblance did not rule out the possibility that

the pills were counterfeit.” She points to nothing in the record that might support such a

suspicion, and the criminalist testified that all of the other submitted suspicious samples

(approximately seven), which were chemically analyzed, did contain methamphetamine

as suspected.3 That is, the other seized substances which police believed were controlled

2 In their respondent’s brief, the People state that “[t]here was no contention that
the pills [the criminalist] identified matched the markings for alprazolam pills, as
identified in the Drug ID Bible.” We believe that this apparent concession reflects an
inadvertent misstatement; surely the People meant to say that there was no contention
that the pills did not match.

3
At trial, appellant urged that the evidence did not show that she possessed
methamphetamine for sale. Very arguably the possession of counterfeit Xanax tablets
would undercut this defense because it would suggest that appellant intended to pass off
[footnote continued on next page]
4
substances were, in fact, controlled substances, which corroborates the belief that pills

that appeared to be industrially generated controlled substances of a specific type were, in

fact, also what they appeared to be. If we may use the phrase noscitur a sociis in

connection with drugs, it was very reasonable for the jury to conclude that apparently

unlawful pills found in the company of definitely unlawful narcotics were also unlawful.

It is true that the jury was required to, and was instructed to, give appellant the

benefit of any reasonable inference in her favor. (CALCRIM 224.) The jury evidently

did not find it reasonable to believe that the pills were not what they appeared to be (and

as noted in the footnote, the “counterfeit” theory was not directly presented to the jury).

We agree with this apparent conclusion. And even if we were to find that the

circumstances and evidence would have supported the contrary finding, where the jury

acted reasonably—as we find it did—we could not reverse the judgment just because we

might have reached another conclusion as triers of fact. (People v. Ceja (1993) 4 Cal.4th

1134, 1139.)

Appellant also argues, and the People concede, that she was improperly charged

and convicted under section 11377, subdivision (a). Although subdivision (a) of that

section on its face applies to possession of “Schedule IV” substances, which includes

alprazolam (§ 11057, subd. (d)(1)), its application to alprazolam is effectively by section

11375. Subdivision (a) of the latter statute provides that “[a]s to the substances specified

in subdivision (c), this section, and not Sections 11377, 11378, 11379, and 11380, shall

[footnote continued from previous page]
the fake tablets on customers. Perhaps that is why the “counterfeit” argument was not
made to the jury.

5
apply.” Subdivision (c) includes “(12) Alprazolam.” Subdivision (b)(2) provides that the

unauthorized possession of a subdivision (c) substance is a misdemeanor, not a

“wobbler,” as would be a violation of section 11377.

As the information expressly alleged that the forbidden possession was of Xanax,

appellant was at all times on notice of the illegal conduct with which she was charged;

and she properly makes no due process argument against the conviction (although the

People proceed to demolish this nonexistent argument). We will provide the relief

appellant requests with respect to this error.

DISPOSITION

The judgment is affirmed and the trial court is directed to modify its records with

respect to count 2 of the information to reflect that appellant was convicted of violating

section 11375, a misdemeanor.4

NOT TO BE PUBLISHED IN OFFICIAL REPORTS

HOLLENHORST
Acting P. J.
We concur:

RICHLI
J.

MILLER
J.

4 The People indicate that we should order correction of the abstract of judgment,
but as appellant was placed on probation no such document was generated. (See Pen.
Code, §§ 1213, 1213.5.)

6

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.